Mission
TO FUND AND SUPPORT PROMISING RESEARCH TO FIND A CURE FOR PSEUDOMYXOMA PERITONEI (PMP), APPENDIX CANCER, AND RELATED PERITONEAL SURFACE MALIGNANCIES (PSM), AND TO FUND EDUCATIONAL PROGRAMS FOR PHYSICIANS AND PATIENS ABOUT THESE DISEASES.
Public Charity
(ACPMP) APPENDIX CANCERPSEUDOMYXOMA PERITONEI RESEARCH FOUNDATION
(ACPMP) APPENDIX CANCERPSEUDOMYXOMA PERITONEI RESEARCH FOUNDATION is a Public Charity headquartered in SPRINGFIELD, PA. Financial data from the 2025 filing: $808K revenue, $777K expenses, $2.2M total assets. 19 publicly reported grants to this organization, totaling roughly $320K, appear in IRS filings.
EIN: 262890160
SPRINGFIELD, PA
Fund Raising & Fund Distribution
NTEE: G12
Latest filing: 2025
Total Revenue$808K
Total Expenses$777K
Total Assets$2.2M
Grant Records19
Funding Total$320K
Filing Years2021–2025
Where $100 goes at (Acpmp) Appendix Cancerpseudomyxoma Peritonei Research Foundation
How (Acpmp) Appendix Cancerpseudomyxoma Peritonei Research Foundation divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$72
Programs
the work itself
$9
Management
running the organization
$19
Fundraising
raising the next dollar
Inside the $72 for programs
$43
Awarded and funded research grants
$26
Provide educational information on pmp and related cancers to patients, families of patients and any other interested parties thru educational sessions, conference exhibits, programs and web
$3
Symposium participation/scholarships & sponsorship
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
For grant recipient's exempt purposes
$51,830
GENERAL SUPPORT
$35,502
GENERAL SUPPORT
$24,803
GENERAL SUPPORT
$24,803
Contribution
$5,222
Showing up to 5 of 19 total records — full history available with membership.
Officers & Directors
SECY/EXEC DIRECTOR
Deborah Shelton
BOARD MEMBER
Dustin Royster
PRESIDENT
James Carroll
TREASURER / VP
Judith Culbertson
BOARD MEMBER
Kim Rowsome
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $808K | $777K | $2.2M |
| 2024 | $764K | $606K | $2.2M |
| 2023 | $592K | $239K | $2.1M |
| 2022 | $467K | $228K | $1.7M |
| 2021 | $864K | $158K | $1.5M |
Between 2021 and 2025, reported annual revenue declined from $864K to $808K (-6%), with total assets most recently reported at $2.2M.
Interactive year-over-year charts and full filing details available with membership.